Literature DB >> 12523676

The role of the critical event committee in a major cardiovascular outcome study.

Anthony Heagerty1, Anne Deverly, Christopher Palmer, Elieser Kaplinsky, Antonio Salvetti, Nils-Gunnar Wahlgren, Christian Funck-Brentano.   

Abstract

Outcome studies in cardiovascular diseases such as hypertension are often based in a number of countries recruiting from multiple centres. This can lead to difficulties in end-point evaluation and classification. The INSIGHT study provided the unique opportunity to examine the role and usefulness of a Critical Event Committee (CEC) established to examine all events occurring in a cohort of 6321 patients and classifying them according to pre-determined criteria. More than 28% of investigator-coded primary events and more than 41% of secondary events were re-classified by the CEC. Particularly difficult diagnoses included myocardial infarction, angina and heart failure, and the database finally analysed was substantially altered after CEC Committee evaluation. Post hoc analysis of the INSIGHT database demonstrated that the primary events compared would have been reduced from 6.3% vs 5.8% of those randomized on nifedipine vs co-amilozide to 5.1% vs 4.7%--an overall reduction of 72 events of 382, a fall of 18.8%. We conclude that a CEC should be a crucial component of any large outcome study and that if all events are subjected to scrutiny, the quality of the database is greatly enhanced.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12523676     DOI: 10.1080/080370502321095294

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  3 in total

1.  Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee.

Authors:  Lorcan P McGarvey; Matthias John; Julie A Anderson; Michael Zvarich; Robert A Wise
Journal:  Thorax       Date:  2007-02-20       Impact factor: 9.139

Review 2.  Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates.

Authors:  Lee Aymar Ndounga Diakou; Ludovic Trinquart; Asbjørn Hróbjartsson; Caroline Barnes; Amelie Yavchitz; Philippe Ravaud; Isabelle Boutron
Journal:  Cochrane Database Syst Rev       Date:  2016-03-10

Review 3.  Current treatment of patients with hypertension: therapeutic implications of INSIGHT.

Authors:  Stefano Taddei; Lorenzo Ghiadoni; Antonio Salvetti
Journal:  Drugs       Date:  2003       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.